Corcept Therapeutics
CORT
#2401
Rank
A$9.62 B
Marketcap
$91.21
Share price
2.65%
Change (1 day)
146.04%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of March 2025 (TTM): 9.10

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.04. At the end of 2024 the company had a P/S ratio of 8.14.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20248.1417.34%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.42-51.45%๐Ÿ‡บ๐Ÿ‡ธ USA
2.52-72.32%๐Ÿ‡บ๐Ÿ‡ธ USA
4.26-53.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
16.7 84.03%๐Ÿ‡บ๐Ÿ‡ธ USA
2.34-74.31%๐Ÿ‡บ๐Ÿ‡ธ USA
3.71-59.26%๐Ÿ‡บ๐Ÿ‡ธ USA
0.9824-89.20%๐Ÿ‡บ๐Ÿ‡ธ USA
5.61-38.29%๐Ÿ‡บ๐Ÿ‡ธ USA
4.76-47.65%๐Ÿ‡บ๐Ÿ‡ธ USA